| Bedford Ear Nose & Throat Clinic Inc | |
|
1706 24th St Bedford IN 47421-4708 | |
| (812) 279-4304 | |
| (812) 275-8441 |
| Full Name | Bedford Ear Nose & Throat Clinic Inc |
|---|---|
| Speciality | Clinic/center |
| Location | 1706 24th St, Bedford, Indiana |
| Authorized Official Name and Position | Prasoon Kumar Samaddar (OWNER) |
| Authorized Official Contact | 8122794304 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Bedford Ear Nose & Throat Clinic Inc Po Box 1178 Bedford IN 47421-1178 Ph: (812) 279-4304 | Bedford Ear Nose & Throat Clinic Inc 1706 24th St Bedford IN 47421-4708 Ph: (812) 279-4304 |
| NPI Number | 1043419823 |
|---|---|
| Provider Enumeration Date | 07/12/2007 |
| Last Update Date | 03/14/2013 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043419823 | NPI | - | NPPES |
| 1184706228 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | 01026176A (Indiana) | Primary |
News Archive
Innovative medical records software developed by geriatricians and informaticians from the Regenstrief Institute and the Indiana University Center for Aging Research will provide more personalized health care for older adult patients, a population at significant risk for mental health decline and disorders.
SHEFFIELD Teaching Hospitals NHS Foundation Trust has been nominated twice for outstanding ideas improving patient care in the Health Service Journal Awards 2014 – one of the most coveted awards in healthcare.
Santaris Pharma announced today that SPC3042, a RNA-based antisense oligonucleotide developed using the company's proprietary Locked Nucleic Acid (LNA) technology, potently blocks survivin, a key survival protein in cancer cells, in both in vitro and in vivo models of prostate cancer. Importantly, SPC3042 works synergistically with the anticancer drug paclitaxel (Taxol) in both model systems.
Metastatic melanoma has a poor prognosis, but treatment with high-dose interleukin-2 (IL2) can extend survival. Now, a combination of IL2 therapy and activation of patients' immune systems using personalized vaccines made from their own tumor cells has been shown to improve survival rates even more than IL2 alone, according to a new article in Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
National Institutes of Health researchers have uncovered a key factor in understanding the elevated cancer risk associated with gene therapy. They conducted research on mice with a rare disease similar to one in humans, hoping their findings may eventually help improve gene therapy for humans. Researchers at the National Human Genome Research Institute, part of NIH, published their research in the Jan. 20, 2015, online issue of the Journal of Clinical Investigation.
› Verified 4 days ago
Pratap Singh Md Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2520 Q St, Suite B, Bedford, IN 47421 Phone: 812-278-8000 Fax: 812-278-8100 | |
Affordable Lab Solutions Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1121 16th St, Bedford, IN 47421 Phone: 812-276-9240 | |
Indiana Community Health Medical Center, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 111 Arrowhead Trl, Bedford, IN 47421 Phone: 812-203-4718 | |
Indiana Health Centers Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2415 Mitchell Rd Ste C, Bedford, IN 47421 Phone: 812-279-6222 | |
St. Vincent Dunn Hospital, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2415 Mitchell Rd, Bedford, IN 47421 Phone: 812-276-1305 | |
Southern Indiana Community Health Care, Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 629 Lincoln Ave, Bedford, IN 47421 Phone: 812-675-4470 Fax: 812-675-4469 |